Corrigendum to “Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study” [World Allergy Organ J 16 (2) (2023) 101167]

Authors

Institutions

Publication Details

Journal
World Allergy Organization Journal
Published
2026-04-17
DOI
https://doi.org/10.1016/j.waojou.2026.101378
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Corrigendum to “Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study” [World Allergy Organ J 16 (2) (2023) 101167]

Cuihong Lian, Maoying Li, Xi Wang
World Allergy Organization Journal
Dermatology and Skin Diseases
article

Corrigendum to “Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study” [World Allergy Organ J 16 (2) (2023) 101167]

Cuihong Lian, Maoying Li, Xi Wang
article en

Abstract

No abstract available for this paper.
World Allergy Organization JournalVol. 19(5)
Longgang Central Hospital (CN), Guangxi University of Chinese Medicine (CN), Shenzhen University Health Science Center (CN), Shenzhen Second People's Hospital (CN)
Openalex Percentile: Top 10%
Dermatology and Skin Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.